Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Monneret, C; Risse, S; Ardouin, P; Gouyette, A
   Synthesis and antitumour activity of a new series of nitrosoureido sugars
   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
   
   C. Monneret et al., "Synthesis and antitumour activity of a new series of nitrosoureido sugars", EUR J MED C, 35(1), 2000, pp. 137-146
2. Angevin, E; Glukhova, L; Pavon, C; Chassevent, A; Terrier-Lacombe, MJ; Goguel, AF; Bougaran, J; Ardouin, P; Court, BH; Perrin, JL; Vallancien, G; Triebel, F; Escudier, B
   Human renal cell carcinoma xenografts in SCID mice: Tumorigenicity correlates with a poor clinical prognosis
   LABORATORY INVESTIGATION
   
   E. Angevin et al., "Human renal cell carcinoma xenografts in SCID mice: Tumorigenicity correlates with a poor clinical prognosis", LAB INV, 79(7), 1999, pp. 879-888
3. RAMIREZ LH; ORLOWSKI S; AN D; BINDOULA G; DZODIC R; ARDOUIN P; BOGNEL C; BELEHRADEK J; MUNCK JN; MIR LM
   ELECTROCHEMOTHERAPY ON LIVER-TUMORS IN RABBITS
   British Journal of Cancer
   
   L.H. Ramirez et al., "ELECTROCHEMOTHERAPY ON LIVER-TUMORS IN RABBITS", British Journal of Cancer, 77(12), 1998, pp. 2104-2111
4. VASSAL G; PONDARRE C; CAPPELLI C; TERRIERLACOMBE MJ; BOLAND I; MORIZET J; BENARD J; VENUAT AM; ARDOUIN P; HARTMANN O; GOUYETTE A
   DNA-TOPOISOMERASE-I, A NEW TARGET FOR THE TREATMENT OF NEUROBLASTOMA
   European journal of cancer
   
   G. Vassal et al., "DNA-TOPOISOMERASE-I, A NEW TARGET FOR THE TREATMENT OF NEUROBLASTOMA", European journal of cancer, 33(12), 1997, pp. 2011-2015
5. TOURINO C; PFLUMIO F; ROUCHES A; ARDOUIN P; VAINCHENKER W; COULOMBEL L
   THE FREQUENCY OF NOD-SCID REPOPULATING STEM-CELLS IN HUMAN CD34-BLOODCELLS LARGELY EXCEEDS THAT PRESENT IN ADULT BONE-MARROW AND MOBILIZEDPERIPHERAL-BLOOD( CORD)
   Experimental hematology
   
   C. Tourino et al., "THE FREQUENCY OF NOD-SCID REPOPULATING STEM-CELLS IN HUMAN CD34-BLOODCELLS LARGELY EXCEEDS THAT PRESENT IN ADULT BONE-MARROW AND MOBILIZEDPERIPHERAL-BLOOD( CORD)", Experimental hematology, 25(8), 1997, pp. 370-370
6. RAMIREZ LH; ZHAO ZX; ROUGIER P; BOGNEL C; DZODIC R; VASSAL G; ARDOUIN P; GOUYETTE A; MUNCK JN
   PHARMACOKINETICS AND ANTITUMOR EFFECTS OF MITOXANTRONE AFTER INTRATUMORAL OR INTRAARTERIAL HEPATIC ADMINISTRATION IN RABBITS
   Cancer chemotherapy and pharmacology
   
   L.H. Ramirez et al., "PHARMACOKINETICS AND ANTITUMOR EFFECTS OF MITOXANTRONE AFTER INTRATUMORAL OR INTRAARTERIAL HEPATIC ADMINISTRATION IN RABBITS", Cancer chemotherapy and pharmacology, 37(4), 1996, pp. 371-376
7. VASSAL G; TERRIERLACOMBE MJ; LELLOUCHTUBIANA A; VALERY CA; SAINTEROSE C; MORIZET J; ARDOUIN P; RIOU G; KALIFA C; GOUYETTE A
   TUMORIGENICITY OF CEREBELLAR PRIMITIVE NEURO-ECTODERMAL TUMORS IN ATHYMIC MICE CORRELATES WITH POOR-PROGNOSIS IN CHILDREN
   International journal of cancer
   
   G. Vassal et al., "TUMORIGENICITY OF CEREBELLAR PRIMITIVE NEURO-ECTODERMAL TUMORS IN ATHYMIC MICE CORRELATES WITH POOR-PROGNOSIS IN CHILDREN", International journal of cancer, 69(2), 1996, pp. 146-151
8. VASSAL G; TERRIERLACOMBE MJ; BISSERY MC; VENUAT AM; GYERGYAY F; BENARD J; MORIZET J; BOLAND I; ARDOUIN P; BRESSACDEPAILLERETS B; GOUYETTE A
   THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS
   British Journal of Cancer
   
   G. Vassal et al., "THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS", British Journal of Cancer, 74(4), 1996, pp. 537-545
9. CARDE P; MASSE A; RAMIREZ L; GRILLON C; BINDOULA G; RADASSI K; ARDOUIN P; SAINTENY F
   THE TETRAPEPTIDE ACSDKP (GORALATIDE) PROTECTS MICE FROM DOXORUBICIN LETHAL TOXICITIES (SURVIVAL AND HEMATOPOIETIC RECOVERY), AND ENHANCES THE EFFECT OF G-CSF
   Blood
   
   P. Carde et al., "THE TETRAPEPTIDE ACSDKP (GORALATIDE) PROTECTS MICE FROM DOXORUBICIN LETHAL TOXICITIES (SURVIVAL AND HEMATOPOIETIC RECOVERY), AND ENHANCES THE EFFECT OF G-CSF", Blood, 86(10), 1995, pp. 2742-2742
10. DONATINI B; BOGNEL C; MUNCK JN; RAMIREZ L; ARDOUIN P; ROUGIER P
    ORAL DICLOFENAC COMBINED WITH INTRA-PORTAL PIRARUBICIN - INCREASED EFFICACY ON LIVER VX2 TUMOR AND HEPATOTOXICITY IN RABBITS
    Journal of cancer research and clinical oncology
    
    B. Donatini et al., "ORAL DICLOFENAC COMBINED WITH INTRA-PORTAL PIRARUBICIN - INCREASED EFFICACY ON LIVER VX2 TUMOR AND HEPATOTOXICITY IN RABBITS", Journal of cancer research and clinical oncology, 120(9), 1994, pp. 529-532
11. RAMIREZ LH; MUNCK JN; ZHAO ZX; BOGNEL C; RICARD M; ARDOUIN P; ROUGIER P; GOUYETTE A
    VERAPAMIL-REVERSING CONCENTRATIONS INDUCE BLOOD-FLOW CHANGES THAT COULD COUNTERACT IN-VIVO THE MDR-1-MODULATING EFFECTS
    Cancer
    
    L.H. Ramirez et al., "VERAPAMIL-REVERSING CONCENTRATIONS INDUCE BLOOD-FLOW CHANGES THAT COULD COUNTERACT IN-VIVO THE MDR-1-MODULATING EFFECTS", Cancer, 74(3), 1994, pp. 810-816
12. BODIS S; BENARD J; BOSQ J; ARDOUIN P; PROST S; VENUAT AM; DIETRICH PY; RAMIREZ L; MAUCH P; PICO JL; HAYAT M
    MDR1 GENE-EXPRESSION IN A MULTIDRUG-RESISTANT HUMAN NON-HODGKINS-LYMPHOMA XENOGRAFT MODEL
    International journal of oncology
    
    S. Bodis et al., "MDR1 GENE-EXPRESSION IN A MULTIDRUG-RESISTANT HUMAN NON-HODGKINS-LYMPHOMA XENOGRAFT MODEL", International journal of oncology, 3(1), 1993, pp. 109-114
13. RAMIREZ LH; MUNCK JN; BOGNEL C; ZHAO Z; ARDOUIN P; POUPON MF; GOUYETTE A; ROUGIER P
    PHARMACOLOGY AND ANTITUMOR EFFECTS OF INTRAPORTAL PIRARUBICIN ON EXPERIMENTAL LIVER METASTASES
    British Journal of Cancer
    
    L.H. Ramirez et al., "PHARMACOLOGY AND ANTITUMOR EFFECTS OF INTRAPORTAL PIRARUBICIN ON EXPERIMENTAL LIVER METASTASES", British Journal of Cancer, 68(2), 1993, pp. 277-281